Clinical and biomarker responses to BI 655064, an antagonistic anti‐CD40 antibody, in patients with active lupus nephritis: a randomized, double‐blind, placebo‐controlled, phase II trial

Autor: David R Jayne, Jürgen Steffgen, Juanita Romero‐Diaz, Ingeborg Bajema, Dimitrios T Boumpas, Kajohnsak Noppakun, Hirofumi Amano, Harold Michael Gomez, Bancha Satirapoj, Yingyos Avihingsanon, Ratana Chawanasuntorapoj, Magdalena Madero, Beata Naumnik, Rhona Recto, Nora Fagan, Ivette Revollo, Jing Wu, Sudha Visvanathan, Richard Furie
Rok vydání: 2023
Předmět:
Zdroj: Arthritis & Rheumatology.
ISSN: 2326-5205
2326-5191
DOI: 10.1002/art.42557
Databáze: OpenAIRE